Cannabidiol, or CBD, has over 110 known active cannabinoids found in the cannabis plant. CBD is identified as one of the major non-psychoactive components of the cannabis plant. The human body contains an endocannabinoid receptor system (ECS) that was found by a Dr. Raphael Mechoulam, a scientist from Israel studying the Cannabis Sativa plant and trying to identify the active component inside it. The ECS is responsible for actively regulating organ systems and other bodily functions to keep them in equilibrium, allowing your body to perform at its optimal level.
CBD has proven neuroprotective effects and its anticancer properties are being investigated at several academic research centers in the United States and elsewhere. A 2010 brain cancer study by California scientists found that CBD “enhances the inhibitory effects of THC on human glioblastoma cell proliferation and survival.” This means that CBD makes THC even more potent as an anticancer substance. Also in 2010, German researchers reported that CBD stimulates neurogenesis, the growth of new brain cells, in adult mammals. In June 2018, the US Food & Drug Administration approved Epidioplex, the first prescription medication to contain CBD. It’s used to treat rare, difficult to control forms of epilepsy.
The ECS is made up of cannabinoid receptors found throughout your body in locations such as the brain, spine, immune cells, major organs, and more. CBD works by indirectly influencing these receptors to achieve the ideal healthy balance within your body systems.
The fact that CBD is therapeutically potent as well as non-intoxicating, and easy to take as a CBD oil, makes it an appealing treatment option for those who are cautious about trying cannabis for the first time.